Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer.

Mathias C, Cardeal Mendes CM, Pondé de Sena E, Dias de Moraes E, Bastos C, Braghiroli MI, Nuñez G, Athanazio R, Alban L, Moore HC, del Giglio A.

Ann Oncol. 2006 Dec;17(12):1792-6. Epub 2006 Sep 15.

2.

Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study.

Safarinejad MR.

J Psychopharmacol. 2011 Mar;25(3):370-8. doi: 10.1177/0269881109351966. Epub 2010 Jan 15.

PMID:
20080928
3.

A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction.

DeBattista C, Solvason B, Poirier J, Kendrick E, Loraas E.

J Clin Psychiatry. 2005 Jul;66(7):844-8.

PMID:
16013899
4.

Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion.

Walker PW, Cole JO, Gardner EA, Hughes AR, Johnston JA, Batey SR, Lineberry CG.

J Clin Psychiatry. 1993 Dec;54(12):459-65.

PMID:
8276736
5.

Bupropion for control of hot flashes in breast cancer survivors: a prospective, double-blind, randomized, crossover, pilot phase II trial.

Nuñez GR, Pinczowski H, Zanellato R, Tateyama L, Schindler F, Fonseca F, Del Giglio A.

J Pain Symptom Manage. 2013 Jun;45(6):969-79. doi: 10.1016/j.jpainsymman.2012.06.011. Epub 2012 Sep 25.

PMID:
23017618
6.

Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction.

Labbate LA, Grimes JB, Hines A, Pollack MH.

Ann Clin Psychiatry. 1997 Dec;9(4):241-5.

PMID:
9511948
7.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024
8.

Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction.

Clayton AH, McGarvey EL, Abouesh AI, Pinkerton RC.

J Clin Psychiatry. 2001 Mar;62(3):185-90.

PMID:
11305705
9.

Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.

Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.

J Clin Psychiatry. 2006 May;67(5):736-46.

PMID:
16841623
10.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900
11.

Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.

Kavoussi RJ, Segraves RT, Hughes AR, Ascher JA, Johnston JA.

J Clin Psychiatry. 1997 Dec;58(12):532-7.

PMID:
9448656
12.

A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women.

Safarinejad MR, Hosseini SY, Asgari MA, Dadkhah F, Taghva A.

BJU Int. 2010 Sep;106(6):832-9. doi: 10.1111/j.1464-410X.2010.09208.x. Epub 2010 Feb 11.

13.

Bupropion improves sexual functioning in depressed minority women: an open-label switch study.

Dobkin RD, Menza M, Marin H, Allen LA, Rousso R, Leiblum SR.

J Clin Psychopharmacol. 2006 Feb;26(1):21-6.

PMID:
16415700
14.

Efficacy of sustained-release bupropion in neuropathic pain: an open-label study.

Semenchuk MR, Davis B.

Clin J Pain. 2000 Mar;16(1):6-11.

PMID:
10741812
15.

The combination of duloxetine and bupropion for treatment-resistant major depressive disorder.

Papakostas GI, Worthington JJ 3rd, Iosifescu DV, Kinrys G, Burns AM, Fisher LB, Homberger CH, Mischoulon D, Fava M.

Depress Anxiety. 2006;23(3):178-81.

PMID:
16528701
16.

Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline.

Modell JG, Katholi CR, Modell JD, DePalma RL.

Clin Pharmacol Ther. 1997 Apr;61(4):476-87.

PMID:
9129565
17.

A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.

Stearns V, Isaacs C, Rowland J, Crawford J, Ellis MJ, Kramer R, Lawrence W, Hanfelt JJ, Hayes DF.

Ann Oncol. 2000 Jan;11(1):17-22.

18.

Sexual function during bupropion or paroxetine treatment of major depressive disorder.

Kennedy SH, Fulton KA, Bagby RM, Greene AL, Cohen NL, Rafi-Tari S.

Can J Psychiatry. 2006 Mar;51(4):234-42.

PMID:
16629348
19.

A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine.

Coleman CC, King BR, Bolden-Watson C, Book MJ, Segraves RT, Richard N, Ascher J, Batey S, Jamerson B, Metz A.

Clin Ther. 2001 Jul;23(7):1040-58.

PMID:
11519769
20.

Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.

Hewett K, Gee MD, Krishen A, Wunderlich HP, Le Clus A, Evoniuk G, Modell JG.

J Psychopharmacol. 2010 Aug;24(8):1209-16. doi: 10.1177/0269881109106953. Epub 2009 Nov 25.

PMID:
19939870
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk